Companies / TwoCells
TwoCells
Hiroshima, Japan
The company develops regenerative medicine using mesenchymal stem cells.
TwoCells, based in Hiroshima, Japan, has 2 investors on file, among them Hiroshima Venture Capital and New Life Capital Partners. Its site was last checked 12 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Hiroshima Venture Capital
78 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (13%), AI & Machine Learning (13%), Industrial & Manufacturing (11%).
See Hiroshima Venture Capital's full profile · Who invests alongside it
More from New Life Capital Partners
4 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See New Life Capital Partners' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get TwoCells and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Hiroshima Venture Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/twocells.com/investors
# also
GET /v1/companies/twocells.com
GET /v1/companies/twocells.com/news